- Home
- MLSS vs NRSN Comparison
MLSS vs NRSN Comparison
Compare MLSS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- NRSN
- Stock Information
- Founded
- MLSS 1989
- NRSN 2017
- Country
- MLSS United States
- NRSN Israel
- Employees
- MLSS N/A
- NRSN N/A
- Industry
- MLSS Industrial Specialties
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- NRSN Health Care
- Exchange
- MLSS Nasdaq
- NRSN Nasdaq
- Market Cap
- MLSS 42.4M
- NRSN 50.1M
- IPO Year
- MLSS 1995
- NRSN 2021
- Fundamental
- Price
- MLSS $0.64
- NRSN $1.26
- Analyst Decision
- MLSS Buy
- NRSN Buy
- Analyst Count
- MLSS 1
- NRSN 2
- Target Price
- MLSS $1.25
- NRSN $14.00
- AVG Volume (30 Days)
- MLSS 942.3K
- NRSN 368.3K
- Earning Date
- MLSS 08-22-2025
- NRSN 09-29-2025
- Dividend Yield
- MLSS N/A
- NRSN N/A
- EPS Growth
- MLSS N/A
- NRSN N/A
- EPS
- MLSS N/A
- NRSN N/A
- Revenue
- MLSS $8,613,503.00
- NRSN N/A
- Revenue This Year
- MLSS $25.28
- NRSN N/A
- Revenue Next Year
- MLSS $20.75
- NRSN N/A
- P/E Ratio
- MLSS N/A
- NRSN N/A
- Revenue Growth
- MLSS N/A
- NRSN N/A
- 52 Week Low
- MLSS $0.38
- NRSN $0.60
- 52 Week High
- MLSS $1.39
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- MLSS 53.53
- NRSN 33.19
- Support Level
- MLSS $0.50
- NRSN $1.00
- Resistance Level
- MLSS $0.68
- NRSN $1.52
- Average True Range (ATR)
- MLSS 0.07
- NRSN 0.21
- MACD
- MLSS 0.02
- NRSN -0.07
- Stochastic Oscillator
- MLSS 86.50
- NRSN 23.64
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.